Embla Medical hf Dirección
Dirección controles de criterios 3/4
El CEO de Embla Medical hf's es Sveinn Solvason , nombrado en Apr 2022, tiene una permanencia de 2.08 años. compensación anual total es $1.18M, compuesta por 48.8% salario y 51.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.016% de las acciones de la empresa, por valor de DKK1.98M. La antigüedad media del equipo directivo y de la junta directiva es de 2.1 años y 15.3 años, respectivamente.
Información clave
Sveinn Solvason
Chief Executive Officer (CEO)
US$1.2m
Compensación total
| Porcentaje del salario del CEO | 48.8% |
| Permanencia del CEO | 2.2yrs |
| Participación del CEO | 0.02% |
| Permanencia media de la dirección | 2.2yrs |
| Promedio de permanencia en la Junta Directiva | 15.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings
May 14
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 26A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)
Apr 10Is Össur hf (CPH:OSSR) Using Too Much Debt?
Mar 23Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E
Jan 21Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 03Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Nov 28Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Nov 08A Look At The Fair Value Of Össur hf. (CPH:OSSR)
Sep 23We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt
Aug 21Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital
Jul 18Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 14Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
May 19Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Mar 14A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)
Jan 21These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well
Dec 22There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Dec 07Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?
Sep 21Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Sep 02Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly
Aug 16Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price
Jun 16Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends
Jun 01Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?
May 08Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around
Feb 22Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report
Feb 03Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Nov 25Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)
Oct 17Is Össur hf (CPH:OSSR) A Risky Investment?
Sep 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
Aug 21Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively
Jul 11Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly
May 28Calculating The Fair Value Of Össur hf. (CPH:OSSR)
May 07There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital
Mar 25We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right
Mar 02We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt
Feb 22Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?
Feb 09What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?
Jan 26Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain
Jan 08
We're Watching These Trends At Össur hf (CPH:OSSR)
Dec 21Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | US$57m |
| Dec 31 2023 | US$1m | US$576k | US$58m |
| Sep 30 2023 | n/a | n/a | US$52m |
| Jun 30 2023 | n/a | n/a | US$45m |
| Mar 31 2023 | n/a | n/a | US$43m |
| Dec 31 2022 | US$780k | US$409k | US$43m |
Compensación vs. Mercado: La compensación total ($USD1.18M) de Sveinn está en línea con el promedio de empresas de tamaño similar en el mercado Danish ($USD1.61M).
Compensación vs. Ingresos: La compensación de Sveinn ha aumentado más de un 20% en el último año.
CEO
Sveinn Solvason (46 yo)
2.2yrs
Permanencia
US$1,180,000
Compensación
Mr. Sveinn Solvason had been Chief Financial Officer of Embla Medical hf. (formerly known as ssur hf.) since May 2013 until April 1, 2022 and serves as its President & CEO since April 1, 2022.Mr. Solvaso...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President & CEO | 2.2yrs | US$1.18m | 0.016% $ 1.9m | |
| Founder | no data | US$25.00k | sin datos | |
| Chief Financial Officer | 1.8yrs | sin datos | sin datos | |
| Chief Operating Officer | less than a year | sin datos | sin datos | |
| Investor Relations Director | no data | sin datos | sin datos | |
| Executive Vice President of People | no data | US$242.00k | 0.0083% $ 987.5k | |
| Chief Commercial Officer | no data | US$600.00k | 0.0030% $ 357.3k | |
| Executive Vice President of EMEA & APAC | 6.6yrs | sin datos | 0.023% $ 2.7m | |
| President of Americas | no data | sin datos | 0.0031% $ 368.1k | |
| Executive Vice President of Research & Development | 2.2yrs | sin datos | 0.00014% $ 16.7k |
2.2yrs
Permanencia media
50yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de EMBLA se considera experimentado (2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman of the Board | 19.4yrs | US$108.00k | 0.048% $ 5.7m | |
| Vice Chairman of the Board | 16.4yrs | US$72.00k | sin datos | |
| Independent Director | 11.3yrs | US$43.00k | 0.0062% $ 733.7k | |
| Director | 15.4yrs | US$50.00k | sin datos | |
| Independent Director | 3.3yrs | US$43.00k | sin datos |
15.4yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de EMBLA son experimentados ( 15.3 años antigüedad media).